Home Newsfeeds Saudi Oil Chief Says OPEC+ Will Stay Cautious on Production

Saudi Oil Chief Says OPEC+ Will Stay Cautious on Production

-Bloomberg https://www.bloomberg.com/news/articles/2022-11-11/saudi-oil-chief-says-opec-will-remain-cautious-on-production#xj4y7vzkg?leadSource=uverify%20wall

byCharles Gross

November 11, 2022

1 minute read

-Bloomberg

https://www.bloomberg.com/news/articles/2022-11-11/saudi-oil-chief-says-opec-will-remain-cautious-on-production#xj4y7vzkg?leadSource=uverify%20wall

EF Hutton Initiates Coverage On Modine Manufacturing with Buy Rating, Announces Price Target of $32

By Benzinga Newsdesk

January 17, 8:46 AM

EF Hutton analyst Tim Moore initiates coverage on Modine Manufacturing (NYSE:MOD) with a Buy rating and announces Price Target of $32.

MOD

News

SKYX Announces Product Collaboration With World Leading Lighting Company Kichler For The Builder Segment As SKYX Continues To Enhance Its Market Penetration

By Benzinga Newsdesk

November 29, 9:38 AM

SKYX will Feature its Advanced and Smart Plug & Play Technology on Kichler's High-End Designed Light Fixtures and Ceiling Fans at the Upcoming International Builders' Show (IBS) for the Builder, Professional and

SKYX

Mizuho Maintains Buy on Leap Therapeutics, Lowers Price Target to $2

By Benzinga Newsdesk

March 17, 9:06 AM

Mizuho analyst Mara Goldstein maintains Leap Therapeutics (NASDAQ:LPTX) with a Buy and lowers the price target from $3 to $2.

LPTX

Morgan Stanley Maintains Equal-Weight on Warner Bros.Discovery, Lowers Price Target to $14

By Benzinga Newsdesk

December 2, 10:38 AM

Morgan Stanley analyst Benjamin Swinburne maintains Warner Bros.Discovery (NASDAQ:WBD) with a Equal-Weight and lowers the price target from $16 to $14.

WBD

Saudi Oil Chief Says OPEC+ Will Stay Cautious on Production

Related Posts

EF Hutton Initiates Coverage On Modine Manufacturing with Buy Rating, Announces Price Target of $32

SKYX Announces Product Collaboration With World Leading Lighting Company Kichler For The Builder Segment As SKYX Continues To Enhance Its Market Penetration

Mizuho Maintains Buy on Leap Therapeutics, Lowers Price Target to $2

Morgan Stanley Maintains Equal-Weight on Warner Bros.Discovery, Lowers Price Target to $14